Access Statistics for Christopher Mark Snyder

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Advance Market Commitments: Insights from Theory and Experience 0 0 0 30 2 7 12 126
An Empirical Study of Pricing Strategies in an Online Market with High-Frequency Price Information 0 0 1 35 0 4 11 265
An Optimal Mechanism to Fund the Development of Vaccines Against Emerging Epidemics 0 0 0 18 4 9 13 24
Authors' response to Unjournal evaluations of "Advance Market Commitments: Insights from Theory and Practice" 0 0 1 1 3 7 13 15
Calculating the Costs and Benefits of Advance Preparations for Future Pandemics 0 0 0 18 5 10 13 43
Can Operation Warp Speed Serve as a Model for Accelerating Innovations Beyond COVID Vaccines? 0 0 0 2 0 5 9 13
Cite Unseen: Theory and Evidence on the Effect of Open Access on Cites to Academic Articles Across the Quality Spectrum 0 0 0 10 1 12 20 51
Cite unseen: Theory and evidence on the effect of open access on cites to academic articles across the quality spectrum 0 0 0 0 0 4 6 14
Communication in Vertical Markets: Experimental Evidence 0 0 0 35 1 15 20 80
Communication in Vertically Related Markets: Experimental Evidence 0 0 0 29 0 4 6 36
Communication in vertical markets: Experimental evidence 0 0 0 50 4 29 33 101
Costs of Managerial Attention and Activity as a Source of Sticky Prices: Structural Estimates from an Online Market 0 0 0 9 0 1 5 38
Costs of Managerial Attention and Activity as a Source of Sticky Prices: Structural Estimates from an Online Market 0 0 0 16 0 5 6 49
Could Vaccine Dose Stretching Reduce COVID-19 Deaths? 0 0 0 7 0 4 4 52
Could Vaccine Dose Stretching Reduce COVID-19 Deaths? 0 0 0 10 1 7 9 48
Designing Advance Market Commitments for New Vaccines 0 0 0 6 1 6 7 35
Designing Advance Market Commitments for New Vaccines 0 0 3 36 0 13 32 128
Do Buyer-Size Discounts Depend on the Curvature of the Surplus Function? Experimental Tests of Bargaining Models 0 1 1 71 0 7 8 431
Does Online Availability Increase Citations? Theory and Evidence from a Panel of Economics and Business Journals 1 1 1 5 1 5 7 33
Expanding Capacity for Vaccines Against Covid-19 and Future Pandemics: A Review of Economic Issues 0 0 0 10 0 5 10 39
IDENTIFYING THE EFFECT OF OPEN ACCESS ON CITATIONS USING A PANEL OF SCIENCE JOURNALS 0 0 0 1 1 10 13 19
Information Sharing and Competition in the Motor Vehicle Industry 0 0 0 2 1 9 11 40
Information sharing and competition in the motor vehicle industry 0 0 0 252 2 10 12 1,103
Investing in Vaccines to Mitigate Harm from COVID-19 and Future Pandemics 0 0 0 7 1 5 8 14
Money Isn’t Everything: Estimating the Prestige Value of Winning Cutthroat Kitchen from Overbidding in Sabotage Auctions 0 0 0 3 1 4 9 13
Open Access as a Crude Solution to a Hold-Up Problem in the Two-Sided Market for Academic Journals 0 0 0 0 0 1 3 6
Open Access as a Crude Solution to a Hold-up Problem in the Two-Sided Market for Academic Journals 0 0 0 66 1 13 15 70
Open Access as a Crude Solution to a Hold‐Up Problem in the Two‐Sided Market for Academic Journals 0 0 0 0 0 4 6 9
Optimal Subsidies for Prevention of Infectious Disease 0 0 1 5 1 5 8 35
Optimal Vaccine Subsidies for Endemic and Epidemic Diseases 0 0 0 17 2 5 10 40
Optimal Vaccine Subsidies for Endemic and Epidemic Diseases 0 0 0 19 4 13 16 75
Preparing for a Pandemic: Accelerating Vaccine Availability 0 0 0 11 0 5 9 88
Preparing for a Pandemic: Accelerating Vaccine Availability 0 0 0 26 0 3 6 83
Preparing for a Pandemic: Accelerating Vaccine Availability 0 0 0 2 1 3 5 14
Preventives Versus Treatments 0 0 0 32 3 9 14 157
Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global D 0 0 1 15 2 9 10 58
Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals 0 0 0 45 1 6 10 99
Property Rights and Incomplete Contracts: Dealing with Nuisance 0 0 0 0 0 5 7 1,031
Property Rights, Incomplete Contracts, and Social Harm 0 0 0 0 0 4 7 828
Quantifying the Social Value of a Universal COVID-19 Vaccine and Incentivizing Its Development 0 0 1 7 3 11 16 27
Revealed Growth: A Method for Bounding the Elasticity of Demand with an Application to Assessing the Antitrust Remedy in the Du Pont Decision 0 0 0 14 0 2 2 16
Round Bidding in Auctions 4 8 8 8 3 16 16 16
Sniff Tests as a Screen in the Publication Process: Throwing out the Wheat with the Chaff 0 0 0 14 0 6 6 48
Sniff Tests in Economics: Aggregate Distribution of Their Probability Values and Implications for Publication Bias 0 0 0 11 0 8 10 29
Targeting Employees for Corporate Crime and Preventing Their Indemnification 0 0 0 0 0 2 3 5
Testing Fractional doses of COVID-19 Vaccines 0 0 0 7 0 10 13 52
Testing fractional doses of COVID-19 vaccines 0 0 0 3 5 11 12 28
The Economics of Open-Access Journals 0 0 0 131 9 18 20 511
The Economics of Open-Access Journals 0 0 0 0 0 8 10 16
Vaccines vs. Preventives 0 0 0 10 3 8 11 70
When Is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity 0 0 0 1 1 5 5 35
When Is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity 0 0 0 21 6 14 16 115
When Is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity - Working Paper 334 0 0 0 26 4 9 13 72
When is Prevention More Profitable than Cure? 0 0 0 0 0 7 12 16
When is Prevention More Profitable than Cure? 0 0 0 6 1 5 7 65
Why Are Drugs More Profitable Than Vaccines? 0 0 0 129 5 25 30 505
Why is There No AIDS Vaccine? 0 0 0 8 1 8 14 85
Worst-Case Bounds on R&D and Pricing Distortions: Theory with an Application Assuming Consumer Values Follow the World Income Distribution 0 0 0 21 1 6 6 55
Total Working Papers 5 10 18 1,318 86 461 645 7,169
1 registered items for which data could not be found

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
2004 International industrial organization conference 0 0 0 2 0 1 3 15
A Dynamic Theory of Countervailing Power 0 1 4 273 1 4 12 1,609
A Simple Method for Bounding the Elasticity of Growing Demand with Applications to the Analysis of Historic Antitrust Cases 0 0 0 10 0 5 5 28
A solution to the hold-up problem involving gradual investment 0 0 2 63 1 5 10 247
Academic Journal Prices in a Digital Age: A Two-Sided Market Model 0 1 1 77 3 9 9 256
Advance Market Commitments: Insights from Theory and Experience 0 0 1 24 4 11 16 109
An empirical analysis of information sharing among U.S. automakers 0 0 0 0 0 4 4 10
An optimal mechanism to fund the development of vaccines against emerging epidemics 0 0 0 1 3 10 14 25
Bidding behavior in the department of defense's commercial activities competitions 0 0 0 0 3 8 9 84
Bounding the benefits of stochastic auditing: The case of risk-neutral agents 0 0 0 67 2 8 10 476
Bounding the relative profitability of price discrimination 0 0 0 25 0 2 5 113
COUNTERVAILING POWER IN WHOLESALE PHARMACEUTICALS* 0 0 1 46 3 12 20 258
Calculating the Costs and Benefits of Advance Preparations for Future Pandemics 0 0 4 5 2 11 24 39
Can Operation Warp Speed Serve as a Model for Accelerating Innovations beyond COVID Vaccines? 0 1 2 3 1 6 18 20
Cite unseen: Theory and evidence on the effect of open access on cites to academic articles across the quality spectrum 0 0 0 0 0 3 9 17
Collusion with secret price cuts: an experimental investigation 0 0 1 172 3 8 15 947
Communication in vertical markets: Experimental evidence 0 1 2 41 2 6 15 183
Designing Advance Market Commitments for New Vaccines 0 1 3 4 4 10 17 23
Do buyer-size discounts depend on the curvature of the surplus function? Experimental tests of bargaining models 0 0 0 4 0 4 8 45
Does Online Availability Increase Citations? Theory and Evidence from a Panel of Economics and Business Journals 1 1 1 43 5 17 21 210
Dynamic Adjustment in the U.S. Higher Education Industry, 1955--1997 0 0 0 48 0 2 5 230
Expanding capacity for vaccines against Covid-19 and future pandemics: a review of economic issues 0 0 0 2 0 5 8 19
Hope Therapy in a Community Sample: A Pilot Investigation 0 1 3 59 2 10 18 199
IDENTIFYING THE EFFECT OF OPEN ACCESS ON CITATIONS USING A PANEL OF SCIENCE JOURNALS 0 0 0 8 0 8 17 91
Information Sharing and Competition in the Motor Vehicle Industry 0 0 4 81 1 7 16 331
International industrial organization conference 0 0 0 0 1 2 4 49
International industrial organization conference (5th annual) 0 0 0 1 1 3 3 19
Introduction to the 2003 International Industrial Organization Conference Special Issue 0 0 0 18 0 4 4 114
Introduction to the 2003 International Industrial Organization Conference Special Issue 0 0 0 10 0 2 5 74
Introduction to the 2004 International Industrial Organization Conference Special Issue 0 0 0 19 0 5 5 125
Introduction to the 2005 International Industrial Organization Conference Special Issue 0 0 0 24 0 2 3 124
Introduction to the Special Issue on “The Intersection Between Industrial Organization and Healthcare Economics” 0 0 0 10 4 9 14 67
Is No. News Bad News? Information Transmission and the Role of "Early Warning" in the Principal-Agent Model 0 2 3 193 1 9 16 962
Loan Commitments and the Debt Overhang Problem 0 0 0 4 0 4 5 40
Multiproject contact in research joint ventures: evidence and theory 0 0 0 17 5 11 12 115
Negotiation and Renegotiation of Optimal Financial Contracts under the Threat of Predation 0 0 0 28 5 11 13 133
Open Access and Academic Journal Quality 0 0 1 36 2 6 9 213
Open Access as a Crude Solution to a Hold‐Up Problem in the Two‐Sided Market for Academic Journals 0 0 0 9 2 6 10 52
Optimal Vaccine Subsidies for Epidemic Diseases 0 0 3 14 1 8 26 53
Optimal vaccine subsidies for endemic diseases 0 0 0 4 8 21 23 33
Preparing for a Pandemic: Accelerating Vaccine Availability 0 0 1 18 2 6 15 64
Preventives Versus Treatments 0 0 0 42 2 5 14 283
Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals 0 0 0 8 3 9 11 65
Quantifying the social value of a universal COVID-19 vaccine and incentivizing its development 0 0 1 2 0 5 9 10
Reducing Government Spending With Privatization Competitions: A Study Of The Department Of Defense Experience 0 0 0 48 0 4 5 299
Should Firms be Allowed to Indemnify Their Employees for Sanctions? 0 0 0 17 2 4 8 184
THE INFLUENCE OF EXPERT REVIEWS ON CONSUMER DEMAND FOR EXPERIENCE GOODS: A CASE STUDY OF MOVIE CRITICS* 0 1 5 273 5 15 30 1,018
Testing fractional doses of COVID-19 vaccines 0 0 0 2 2 5 8 22
The Role Of Firm Size In Bilateral Bargaining: A Study Of The Cable Television Industry 3 6 12 346 5 13 30 914
The identity of the generator in the problem of social cost 0 0 0 13 0 1 4 122
Vertical Foreclosure in Experimental Markets 0 0 0 0 1 7 9 529
Why do larger buyers pay lower prices? Intense supplier competition 0 0 0 158 1 8 9 407
Total Journal Articles 4 16 55 2,372 93 361 612 11,674

Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Can Operation Warp Speed Serve as a Model for Accelerating Innovations beyond COVID Vaccines? 0 0 0 4 0 10 12 26
Corporate Crime 0 0 2 43 0 2 6 91
Total Chapters 0 0 2 47 0 12 18 117

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Since October 2025, abstract view statistics are potentially heavily influenced by traffic from AI bots and tools that we could not eliminate despite our best efforts.

Statistics updated 2026-03-04